About
Community
Our Researchers
Funded Research
Team login
Cancer projects
Research Funded by
Box Rallies
state
WA
QLD
SA
VIC
NSW
year
2029
2028
2027
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
type
All Cancer Types
Bladder Cancer
Bowel Cancer
Brain Cancer
Breast and Prostate Cancer
Breast Cancer
Cancer Treatment Side Effects
Childhood Cancer
Colorectal and Lung Cancer
Colorectal Cancer
Gastrointestinal Cancer
Glioblastoma
Immune Therapy
Leukaemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Mesothelioma
Myeloma
Neuroblastoma
Osteosarcoma
Ovarian Cancer
Pancreatic and Lung Cancer
Pancreatic Cancer
Prostate Cancer
Stomach Cancer
Featured
Research
Professor Booth and his team are using AI to enhance radiotherapy effectiveness.
Explore Research
Predicting clinical response to breast cancer therapy – the immune signature approach
NSW
Read more
Preventing people with immune deficiencies from developing cancer
NSW
Read more
Preventing the outgrowth of cancers that spread to bone
NSW
Read more
Priming with Belinostat to chemo-sensitise high-risk neuroblastoma
NSW
Read more
Protein Biosignatures for Predicting Recurrence of Stage II Colorectal Cancer
NSW
Read more
Rational Targeting of the Hedgehog Pathway to Treat Osteosarcoma
NSW
Read more
Real-time dose monitoring for patient safety in radiation therapy.
NSW
Read more
Resolving prostate cancer: Elucidating the epigenetics of tumour microenvironment cells to advance understanding of disease aetiology and improve patient diagnosis
NSW
Read more
Reversing treatment resistance in ER+ breast cancer
NSW
Read more
Reversing treatment resistance in melanoma
NSW
Read more
Selective manipulation of tumour-stroma signalling as a novel precision medicine approach: targeting treatment resistance in pancreatic cancer
NSW
Read more
Selective targeting of CDK4 to improve breast and prostate cancer treatment
SA
Read more
Switching off the spread of triple-negative breast cancer
NSW
Read more
Targeting aggressive cancers that use the Alternative Lengthening of Telomeres (ALT) mechanism
NSW
Read more
Targeting Innate Chemoresistance in Lung Adenocarcinoma
NSW
Read more
Targeting lipid metabolism in pancreatic ductal adenocarcinoma to improve chemotherapy efficacy
NSW
Read more
Targeting obesity-related factors to enhance liver cancer therapies
NSW
Read more
Targeting pancreatic cancer (PC) via anti-fibrotic NID2 therapy and Gemcitabine/Abraxane chemotherapy treatment: stratifying PC therapy
NSW
Read more
Previous
Next